| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2011PLoSO...625475T |
| P356 | DOI | 10.1371/JOURNAL.PONE.0025475 |
| P932 | PMC publication ID | 3183029 |
| P698 | PubMed publication ID | 21980472 |
| P5875 | ResearchGate publication ID | 51700137 |
| P2093 | author name string | Hien T Tran | |
| Laura Sanchez | |||
| David L Brody | |||
| Thomas J Esparza | |||
| P2860 | cites work | The occult aftermath of boxing | Q24562155 |
| Alzheimer's disease: genes, proteins, and therapy | Q28131806 | ||
| Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase | Q28188098 | ||
| Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction | Q29547778 | ||
| Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated Abeta42 accumulation in a novel Alzheimer transgenic model | Q30478167 | ||
| Evidence that neurones accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer's disease | Q32028060 | ||
| Detailed immunohistochemical characterization of temporal and spatial progression of Alzheimer's disease-related pathologies in male triple-transgenic mice | Q33359744 | ||
| Beta amyloid protein deposition in the brain after severe head injury: implications for the pathogenesis of Alzheimer's disease | Q33732327 | ||
| Traumatic brain injury reduces soluble extracellular amyloid-β in mice: A methodologically novel combined microdialysis-controlled cortical impact study | Q34204176 | ||
| Incidence, risk factors and prevention of mild traumatic brain injury: results of the WHO Collaborating Centre Task Force on Mild Traumatic Brain Injury | Q34313467 | ||
| Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes | Q34452028 | ||
| A lack of amyloid beta plaques despite persistent accumulation of amyloid beta in axons of long-term survivors of traumatic brain injury | Q34458328 | ||
| Intraneuronal APP, not free Aβ peptides in 3xTg-AD mice: implications for tau versus Aβ-mediated Alzheimer neurodegeneration | Q35055486 | ||
| Long-term accumulation of amyloid-beta, beta-secretase, presenilin-1, and caspase-3 in damaged axons following brain trauma | Q35103035 | ||
| Head injury as a risk factor for Alzheimer's disease: the evidence 10 years on; a partial replication. | Q35156240 | ||
| Intraneuronal Abeta42 accumulation in human brain. | Q35793325 | ||
| Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease | Q35998995 | ||
| Selective cytotoxicity of intracellular amyloid beta peptide1-42 through p53 and Bax in cultured primary human neurons | Q36324215 | ||
| Electromagnetic controlled cortical impact device for precise, graded experimental traumatic brain injury | Q36731362 | ||
| Diffusion tensor imaging reliably detects experimental traumatic axonal injury and indicates approximate time of injury | Q36926127 | ||
| Traumatic brain injury and amyloid-β pathology: a link to Alzheimer's disease? | Q37691554 | ||
| Multiple proteins implicated in neurodegenerative diseases accumulate in axons after brain trauma in humans | Q37691584 | ||
| Controlled cortical impact traumatic brain injury in 3xTg-AD mice causes acute intra-axonal amyloid-β accumulation and independently accelerates the development of tau abnormalities | Q39734068 | ||
| Head injuries and cognitive decline among older adults: a population-based study | Q40823718 | ||
| Mild traumatic brain injury to the infant mouse causes robust white matter axonal degeneration which precedes apoptotic death of cortical and thalamic neurons. | Q40987456 | ||
| Post-traumatic Alzheimer's disease: preponderance of a single plaque type | Q41188621 | ||
| Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils | Q43718666 | ||
| Alterations in glucose metabolism induce hypothermia leading to tau hyperphosphorylation through differential inhibition of kinase and phosphatase activities: implications for Alzheimer's disease. | Q44795484 | ||
| Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease. | Q46018632 | ||
| Head trauma as a risk factor for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group | Q67903226 | ||
| Documented head injury in early adulthood and risk of Alzheimer's disease and other dementias | Q73172415 | ||
| Time sequence of maturation of dystrophic neurites associated with Abeta deposits in APP/PS1 transgenic mice | Q79322897 | ||
| Phosphoinositides suppress gamma-secretase in both the detergent-soluble and -insoluble states | Q46595840 | ||
| Accumulation of amyloid beta and tau and the formation of neurofilament inclusions following diffuse brain injury in the pig. | Q48105099 | ||
| Tau immunohistochemistry in acute brain injury | Q48190171 | ||
| Traumatic brain injury and time to onset of Alzheimer's disease: a population-based study | Q48308861 | ||
| Amyloid β accumulation in axons after traumatic brain injury in humans | Q48311745 | ||
| Intraneuronal Abeta42 accumulation in Down syndrome brain | Q48443635 | ||
| Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins | Q48601563 | ||
| Intraneuronal Abeta accumulation precedes plaque formation in beta-amyloid precursor protein and presenilin-1 double-transgenic mice | Q48846848 | ||
| Intraneuronal abeta-amyloid precedes development of amyloid plaques in Down syndrome | Q48945429 | ||
| Alzheimer's pathology in human temporal cortex surgically excised after severe brain injury. | Q53264740 | ||
| Axonopathy in an APP/PS1 transgenic mouse model of Alzheimer's disease. | Q53276312 | ||
| Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation. | Q53335187 | ||
| Incidence, risk factors and prevention of mild traumatic brain injury: results of the who collaborating centre task force on mild traumatic brain injury | Q54273217 | ||
| Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau | Q67894826 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e25475 | |
| P577 | publication date | 2011-09-29 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Distinct temporal and anatomical distributions of amyloid-β and tau abnormalities following controlled cortical impact in transgenic mice | |
| P478 | volume | 6 |
| Q35763336 | A neurovascular perspective for long-term changes after brain trauma |
| Q26995259 | Acute and chronic traumatic encephalopathies: pathogenesis and biomarkers |
| Q36955963 | Amyloid-β Peptides and Tau Protein as Biomarkers in Cerebrospinal and Interstitial Fluid Following Traumatic Brain Injury: A Review of Experimental and Clinical Studies |
| Q36585738 | Amyloid-β oligomerization in Alzheimer dementia versus high-pathology controls |
| Q27025951 | Animal models of traumatic brain injury |
| Q39531388 | Array tomography for the detection of non-dilated, injured axons in traumatic brain injury |
| Q37001841 | Brain injury, neuroinflammation and Alzheimer's disease |
| Q47250204 | CNS Injury: Posttranslational Modification of the Tau Protein as a Biomarker |
| Q36346809 | Ccr2 deletion dissociates cavity size and tau pathology after mild traumatic brain injury |
| Q89547106 | Chronic White Matter Degeneration, but No Tau Pathology at One-Year Post-Repetitive Mild Traumatic Brain Injury in a Tau Transgenic Model |
| Q30409194 | Chronic traumatic encephalopathy: clinical-biomarker correlations and current concepts in pathogenesis |
| Q90639131 | Combined Diffusion Tensor Imaging and Quantitative Susceptibility Mapping Discern Discrete Facets of White Matter Pathology Post-injury in the Rodent Brain |
| Q35185668 | Effects of growth hormone-releasing hormone on sleep and brain interstitial fluid amyloid-β in an APP transgenic mouse model |
| Q37573798 | Experimental traumatic brain injury induces rapid aggregation and oligomerization of amyloid-beta in an Alzheimer's disease mouse model |
| Q28396242 | Found in translation: Understanding the biology and behavior of experimental traumatic brain injury |
| Q45412375 | Human apolipoprotein E4 worsens acute axonal pathology but not amyloid-β immunoreactivity after traumatic brain injury in 3xTG-AD mice |
| Q27315716 | Identification of injury specific proteins in a cell culture model of traumatic brain injury |
| Q57162783 | Induction of a transmissible tau pathology by traumatic brain injury |
| Q34325388 | Inflammation and white matter degeneration persist for years after a single traumatic brain injury |
| Q31096804 | Long-Term Effects of Sports Concussions: Bridging the Neurocognitive Repercussions of the Injury with the Newest Neuroimaging Data |
| Q89187503 | Novel therapies for combating chronic neuropathological sequelae of TBI |
| Q36436213 | On the issue of transmissibility of Alzheimer disease: a critical review |
| Q36378416 | Polypathology and dementia after brain trauma: Does brain injury trigger distinct neurodegenerative diseases, or should they be classified together as traumatic encephalopathy? |
| Q38121589 | Predictive markers in traumatic brain injury: opportunities for a serum biosignature |
| Q46180253 | ReMAPping the microtubule landscape: How phosphorylation dictates the activities of microtubule-associated proteins. |
| Q57038711 | Repetitive Concussive and Subconcussive Injury in a Human Tau Mouse Model Results in Chronic Cognitive Dysfunction and Disruption of White Matter Tracts, But Not Tau Pathology |
| Q48202003 | Repetitive mild traumatic brain injury augments tau pathology and glial activation in aged hTau mice |
| Q36539937 | Repetitive traumatic brain injury and development of chronic traumatic encephalopathy: a potential role for biomarkers in diagnosis, prognosis, and treatment? |
| Q38050513 | Review: Axon pathology in age-related neurodegenerative disorders |
| Q98177561 | Sex Differences in Circulating T-Tau Trajectories After Sports-Concussion and Correlation With Outcome |
| Q37103562 | Subacute Changes in Cleavage Processing of Amyloid Precursor Protein and Tau following Penetrating Traumatic Brain Injury |
| Q49052601 | Tau Oligomers Derived from Traumatic Brain Injury Cause Cognitive Impairment and Accelerate Onset of Pathology in Htau Mice |
| Q53403638 | The Inflammatory Continuum of Traumatic Brain Injury and Alzheimer's Disease. |
| Q38835489 | The Pathophysiology of Concussion |
| Q27321301 | The liver X receptor agonist GW3965 improves recovery from mild repetitive traumatic brain injury in mice partly through apolipoprotein E |
| Q35775806 | The new neurometabolic cascade of concussion |
| Q35706415 | The pathophysiology of repetitive concussive traumatic brain injury in experimental models; new developments and open questions |
| Q22242925 | The spectrum of disease in chronic traumatic encephalopathy |
| Q91981508 | Traumatic Brain Injury Induces Tau Aggregation and Spreading |
| Q48213078 | Traumatic Brain Injury as a Trigger of Neurodegeneration |
| Q26824702 | Tumor necrosis factor-induced cerebral insulin resistance in Alzheimer's disease links numerous treatment rationales |
Search more.